RxDoctor Payments Data

Casey Barker, APRN

Family · Great Falls, MTNPI 1750816237

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 93.3% of the total across 127 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 14 manufacturers, the largest accounting for just 23.3% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $843, 2.6 times the $322 reported in 2021. Among family clinicians in MT with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$2,802in general payments, 2019–2025

Across 127 payments — averaging $22.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$654
  • Regeneron Healthcare Solutions, Inc.$631
  • Amgen$439
  • Lilly USA, LLC$264
  • Johnson & Johnson$244
  • E.r. Squibb & Sons, L.L.C.$187
  • plus $384 from 8 others

What the payments were for

  • Food & beverage$2,61493%
  • Education$1887%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,802 in reported general payments places this provider in the 90th percentile of 481 family providers in Montana.

See all family providers in Montana

Medicare billing

Part B allowed, 2024
$106,097
Medicare patients
690
Services billed
3,118

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab83$329,365
Dupixent SyringeDupilumab26$93,055
ZoryveRoflumilast12$10,330
Fluorouracil83$5,562
Betamethasone Dipropionate86$3,155
Metronidazole28$2,544
Clobetasol Propionate41$2,262
Tacrolimus15$2,187
Azelaic Acid13$1,880
Imiquimod46$1,177
ValacyclovirValacyclovir Hcl45$1,072
Nystatin39$828
Econazole Nitrate13$613
Ketoconazole20$479
Triamcinolone Acetonide69$402

Paid to pharmacies, not to this prescriber.

Other family in Great Falls

See the full list for Montana

Where these figures come from

Is this you, or does something look wrong? →